Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Sort 111 results by:

Filter Applied. Clear All
Reset All Filters

Search Results for: Covid vacc /about:blank

Why the Global Protect Life Rule is Right for the U.S. and Nations around the World (2025 Update)

The Mexico City Policy, first introduced in 1984, prohibited U.S. funds for family planning from going to foreign nongovernmental organizations that perform or promote abortion as a method of family planning. In 2017, President Trump restored the MCP and expanded it through Protecting Life in Global...

Strengthening the Pro-Life Safety Net: Federal Response to Perinatal Substance Use

Substance use during pregnancy presents significant health risks, affecting both maternal and fetal health outcomes and often leading to complications that require substantial medical and social intervention. This study provides a comprehensive review of federal policies affecting pregnant and paren...

Strengthening the Pro-Life Safety Net: Federal Housing Policy

Pregnant and parenting women in need face significant challenges with housing that make them a high priority for the allocation of existing federal aid, thereby expanding the pro-life safety net. The U.S. Department of Housing and Urban Development alone now allocates about $70 billion in housing pr...

IVF Industry Regulation in the United States: Changes Are Needed to Protect Embryonic Children and their Families

Federal, state, and professional regulations provide a very limited patchwork of protections for IVF patients, let alone their unborn children created through the procedure. There is a need for improved regulation of the IVF industry, both federally and at the state level.

Prenatal Tax Credits and Child Support for the Unborn: A Literature Review

Prenatal tax credits and child support for the unborn have a firm foundation in common law, as well as statutory and judicial precedent. Prenatal tax credits at the federal, state, and local levels hold out the promise of potentially enhanced birth weights and improved food stability, especially if ...

New Study Reveals FDA Relied on Cherrypicked Data to Approve Dangerous Mail-Order Abortion Drugs

A new peer-reviewed article highlights major flaws in the data used by the U.S. Food and Drug Administration (FDA) to remove medical safeguards and in-person administering of abortion drugs. These flaws illustrate the ongoing problem of lack of quality abortion reporting data in the U.S. as well as ...

A Fact-Free Campaign Against Parents and Unborn Children in Alabama

Recently, Alabama passed a new law that grants immunity from both civil and criminal liability to IVF clinics for destroying human embryos, without parents’ consent and for any reason. This came in the wake of the Alabama supreme court ruling that parents can file suit when, without their consent ...

Filed: CLI Amicus Brief in SCOTUS Case FDA v. Alliance for Hippocratic Medicine

On March 26, SCOTUS will hear oral arguments in the case FDA v. Alliance for Hippocratic Medicine. In the case, AHM argues that the FDA's changes to regulations of the abortion drug mifepristone were "arbitrary and capricious." CLI filed a brief in support of AHM, arguing that abortion with mifepris...